rs1801114

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000395.3(CSF2RB):​c.1954G>A​(p.Val652Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0284 in 1,574,552 control chromosomes in the GnomAD database, including 1,385 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 443 hom., cov: 32)
Exomes 𝑓: 0.026 ( 942 hom. )

Consequence

CSF2RB
NM_000395.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.05

Publications

11 publications found
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
CSF2RB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 5
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary pulmonary alveolar proteinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001535207).
BP6
Variant 22-36937762-G-A is Benign according to our data. Variant chr22-36937762-G-A is described in ClinVar as Benign. ClinVar VariationId is 226550.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RBNM_000395.3 linkc.1954G>A p.Val652Met missense_variant Exon 14 of 14 ENST00000403662.8 NP_000386.1 P32927-1Q6NSJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RBENST00000403662.8 linkc.1954G>A p.Val652Met missense_variant Exon 14 of 14 5 NM_000395.3 ENSP00000384053.3 P32927-1
CSF2RBENST00000406230.5 linkc.1972G>A p.Val658Met missense_variant Exon 13 of 13 1 ENSP00000385271.1 P32927-2

Frequencies

GnomAD3 genomes
AF:
0.0547
AC:
8314
AN:
152102
Hom.:
439
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.139
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.0349
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0676
Gnomad FIN
AF:
0.00442
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0206
Gnomad OTH
AF:
0.0506
GnomAD2 exomes
AF:
0.0304
AC:
5634
AN:
185336
AF XY:
0.0304
show subpopulations
Gnomad AFR exome
AF:
0.141
Gnomad AMR exome
AF:
0.0225
Gnomad ASJ exome
AF:
0.0266
Gnomad EAS exome
AF:
0.000288
Gnomad FIN exome
AF:
0.00487
Gnomad NFE exome
AF:
0.0202
Gnomad OTH exome
AF:
0.0294
GnomAD4 exome
AF:
0.0255
AC:
36326
AN:
1422332
Hom.:
942
Cov.:
35
AF XY:
0.0261
AC XY:
18363
AN XY:
703938
show subpopulations
African (AFR)
AF:
0.152
AC:
4971
AN:
32808
American (AMR)
AF:
0.0240
AC:
898
AN:
37402
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
665
AN:
25380
East Asian (EAS)
AF:
0.000211
AC:
8
AN:
37954
South Asian (SAS)
AF:
0.0556
AC:
4563
AN:
82096
European-Finnish (FIN)
AF:
0.00617
AC:
310
AN:
50218
Middle Eastern (MID)
AF:
0.0577
AC:
330
AN:
5718
European-Non Finnish (NFE)
AF:
0.0208
AC:
22763
AN:
1091850
Other (OTH)
AF:
0.0309
AC:
1818
AN:
58906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2256
4511
6767
9022
11278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
980
1960
2940
3920
4900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0548
AC:
8337
AN:
152220
Hom.:
443
Cov.:
32
AF XY:
0.0531
AC XY:
3953
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.139
AC:
5769
AN:
41516
American (AMR)
AF:
0.0348
AC:
533
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5166
South Asian (SAS)
AF:
0.0676
AC:
326
AN:
4820
European-Finnish (FIN)
AF:
0.00442
AC:
47
AN:
10622
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0206
AC:
1402
AN:
67996
Other (OTH)
AF:
0.0501
AC:
106
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
388
777
1165
1554
1942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0286
Hom.:
240
Bravo
AF:
0.0597
TwinsUK
AF:
0.0216
AC:
80
ALSPAC
AF:
0.0239
AC:
92
ESP6500AA
AF:
0.134
AC:
588
ESP6500EA
AF:
0.0197
AC:
168
ExAC
AF:
0.0290
AC:
3453
Asia WGS
AF:
0.0310
AC:
108
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 31, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val652Met in exon 14 of CSF2RB: This variant is not expected to have clinical si gnificance because it has been identified in 13.4% (588/4378) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs1801114). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
0.30
DANN
Benign
0.64
DEOGEN2
Benign
0.24
T;T;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.34
T;T;T
MetaRNN
Benign
0.0015
T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.0
L;.;.
PhyloP100
-1.1
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.13
N;.;N
REVEL
Benign
0.22
Sift
Benign
0.27
T;.;T
Sift4G
Benign
0.13
T;T;T
Polyphen
0.019
B;.;B
Vest4
0.039
MPC
0.15
ClinPred
0.0022
T
GERP RS
-7.8
Varity_R
0.017
gMVP
0.075
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801114; hg19: chr22-37333804; API